- Home
- CHKP vs BNTX Comparison
CHKP vs BNTX Comparison
Compare CHKP & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHKP
- BNTX
- Stock Information
- Founded
- CHKP 1993
- BNTX 2008
- Country
- CHKP Israel
- BNTX Germany
- Employees
- CHKP N/A
- BNTX N/A
- Industry
- CHKP Computer Software: Prepackaged Software
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CHKP Technology
- BNTX Health Care
- Exchange
- CHKP Nasdaq
- BNTX Nasdaq
- Market Cap
- CHKP 25.0B
- BNTX 25.0B
- IPO Year
- CHKP 1996
- BNTX 2019
- Fundamental
- Price
- CHKP $221.25
- BNTX $106.47
- Analyst Decision
- CHKP Buy
- BNTX Strong Buy
- Analyst Count
- CHKP 26
- BNTX 18
- Target Price
- CHKP $232.33
- BNTX $141.55
- AVG Volume (30 Days)
- CHKP 667.7K
- BNTX 1.1M
- Earning Date
- CHKP 07-23-2025
- BNTX 08-04-2025
- Dividend Yield
- CHKP N/A
- BNTX N/A
- EPS Growth
- CHKP 5.37
- BNTX N/A
- EPS
- CHKP 7.58
- BNTX N/A
- Revenue
- CHKP $2,604,000,000.00
- BNTX $2,968,331,171.00
- Revenue This Year
- CHKP $8.03
- BNTX N/A
- Revenue Next Year
- CHKP $5.88
- BNTX $10.68
- P/E Ratio
- CHKP $28.56
- BNTX N/A
- Revenue Growth
- CHKP 6.40
- BNTX 0.61
- 52 Week Low
- CHKP $163.08
- BNTX $76.53
- 52 Week High
- CHKP $234.36
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- CHKP 49.31
- BNTX 53.76
- Support Level
- CHKP $215.83
- BNTX $102.57
- Resistance Level
- CHKP $227.30
- BNTX $107.51
- Average True Range (ATR)
- CHKP 4.95
- BNTX 2.83
- MACD
- CHKP -0.66
- BNTX -0.25
- Stochastic Oscillator
- CHKP 39.02
- BNTX 56.58
About CHKP Check Point Software Technologies Ltd.
Check Point Software Technologies is a pure-play cybersecurity vendor. The company offers solutions for network, endpoint, cloud, and mobile security in addition to security management. Check Point, a software specialist, sells to enterprises, businesses, and consumers. Around 50% of revenue is generated in Europe, the Middle East, and Africa, 40% from the Americas, and 10% from the Asia-Pacific region. The firm, based in Tel Aviv, Israel, was founded in 1993 and has about 5,000 employees.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.